glp-1 market size New Demand in an Old Glucagon Like Peptide-1 (GLP-1) Agonists

Although it is not included in the diagnostic criteria of PCOS, there is a crucial role of this metabolic impairment, which along with hormonal ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options to reach the market and help address a shortage.

Retatrutide showed up to 28.3% weight loss in Phase 3 trials but is not yet FDA approved

Trulicity offers a simple, once-weekly way to control type 2 diabetes and prevent cardiovascular disease (CVD) or help with existing CVD

Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children